Catherinepan (Talk | contribs) |
Catherinepan (Talk | contribs) |
||
Line 6: | Line 6: | ||
font-family:GeosansLight; | font-family:GeosansLight; | ||
-webkit-text-stroke: 1px #45827A; | -webkit-text-stroke: 1px #45827A; | ||
− | margin-top: | + | margin-top: 100px; |
+ | margin-left: 80px;"> | ||
UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin </h1> | UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin </h1> | ||
− | <p style="font-family:GeosansLight; font-size: 15px;"> <b>Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds. </b> </p> | + | <p style="font-family:GeosansLight; font-size: 15px; margin-left: 80px; margin-right: 80px;"> <b>Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds. </b> </p> |
</html> | </html> |
Revision as of 22:47, 19 August 2018
UBC iGEM 2018: Distributed Metabolic Pathway of Naringenin
Dividing metabolism amongst microbial communities has shown huge potential for the large-scale production of chemical products. Unfortunately, optimizing the population dynamics of the individual strain modules remains a challenge (Jones & Wang, 2018). Our goal is to improve the production of naringenin and its pharmaceutically significant derivatives, which have anti-cancer and anti-inflammatory properties, by distributing the synthesis of a naringenin derivative between two E. coli strains and optimizing their relative proportions in co-culture. One strain will produce naringenin from glucose and the second strain will create the naringenin derivative. We will regulate the ratio of the two strains using a biosensor and a toehold switch. This will couple cell growth with the concentration of naringenin, allowing the co-culture to self-optimize and increase naringenin production. Using our system, we will have demonstrated a novel way to optimize microbial polycultures for the synthesis of metabolically complex compounds.